Photo taken from Fred R. Hirsch/X
Aug 25, 2024, 12:38
Fred R. Hirsch: What is the real impact of neo-adjuvant versus adjuvant therapy
Fred R. Hirsch, CEO of International Association for the Study of Lung Cancer, shared a post on X:
“I think we still need to know what is the real impact of neo-adjuvant versus adjuvant therapy.
We need to see results from prospective study (-ies) where each component is studied separately.”
Source: Fred R. Hirsch/X
Fred R. Hirsch is the CEO of International Association for the Study of Lung Cancer. He is a Professor and the Executive Director of the Thoracic Center at Tisch Cancer Institute, Mount Sinai. He is also a Professor Of Medicine and Pathology at the University of Colorado.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:59
Dec 22, 2024, 05:31